CNTX Dividend History & Analysis | N/A Yield
CNTX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| SIGA | 598 M | 7.22% | 12.6% |
| PFE | 140,547 M | 8.81% | 7.89% |
| OGN | 1,648 M | 9.13% | 2.20% |
| BMY | 89,213 M | 5.44% | 5.06% |
| TAK | 44,447 M | 4.99% | 5.19% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| RPRX | 21,583 M | 29.4% | 100% |
| ZTS | 63,490 M | 21.2% | 100% |
| LLY | 739,980 M | 15.1% | 99.5% |
| SIGA | 598 M | 15.5% | 98.8% |
| RDY | 12,030 M | 28.0% | 87.3% |
Similar Stocks with Attractive Dividends - Compare CNTX Dividends with its Peer-Group
7.22% Yield
2.95% Yield
3.76% Yield
3.37% Yield
4.45% Yield
3.37% Yield
CNTX Dividend History: as of October 2025
No dividends paid yet.CNTX Dividend FAQ
Context Therapeutics Inc. (NASDAQ:CNTX) is a U.S. biopharma focused on solid-tumor therapies, centered on its lead bispecific antibody CTIM-76, which links anti-Claudin 6 (CLDN6) and anti-CD3 to direct T-cell killing of CLDN6-positive cancer cells. The firm’s development program is supported by a licensing and collaboration agreement with Integral Molecular, Inc., granting access to CLDN6-targeted antibody technology. Founded in 2015 and based in Philadelphia, the company trades under the “Pharmaceuticals” sub-industry in the GICS classification.
What is the Dividend Yield of CNTX?
As of October 2025, CNTX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 1.13.Does CNTX pay a dividend?
As of October 2025 CNTX does not pay a dividend.How often does CNTX pay dividends?
Over the last 12 months, CNTX has issued dividend payments.Will CNTX pay dividends in 2025?
The next Ex-Dividend date for Context Therapeutics (CNTX) is currently unknown.What is the next Ex-Dividend Date for CNTX?
The next Ex-Dividend date for Context Therapeutics (CNTX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of CNTX?
CNTX's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of CNTX?
CNTX's 5-Year Yield on Cost is -%. If you bought CNTX's shares at 5.10 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of CNTX?
CNTX Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does CNTX have a good Dividend Yield?
CNTX`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of CNTX?
The Dividend Payout Ratio of CNTX is unknown.What is the Dividend Rating of CNTX?
CNTX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-10-18 04:36